For every cannabis regulatory regime come lessons for the implementation of similar laws elsewhere. This article surveys cannabis legalization models across America, Jamaica, the Netherlands, and more.
Read more →Even staunch opponent to marijuana legalization, Smart Approaches to Marijuana (SAM) opposes the criminalization of marijuana. This articles explores contending minds on the issue of marijuana legalization, and why one advocate believes noncommercial legalization is the most viable alternative to the commercial legalization of pot.
Read more →In the following transcript, Kevin Sabet, c0-funder of Smart Approaches to Marijuana, opposes marijuana legalization on the grounds that legalization would inevitably lead to the emergence of a immovable “Big Marijuana” industry the likes of big Tobacco. Remarking that drug policy academics have difficulty “transferring their theories and getting them adopted in governments,” he sees prohibition as the...
Read more →Marijuana clinical trials underway in New South Wales, Australia press on as other states anticipate the results. In the meantime, Beau Kilmer of the Rand Corporation, a bipartisan global think tank, addressed police officials in Brisbane, Australia on the benefits of marijuana legalization and purveyed several models capable of doing so.
Read more →In a much anticipated press conference, Senators Rand Paul, Kirsten Gillibrand, and Corey Booker will discuss their bill aimed to end the federal prohibition of cannabis. Concerns raised include whether or not the bill will address the rescheduling of cannabis as a Schedule I drug, which prohibits clinical studies on humans deemed essential to determining the pharmacological benefits of various...
Read more →Professor of criminal justice and drug policy, Mark Kleiman, discusses public health concerns, taxation, federal prohibition and commercialization, as they relate to cannabis.
Read more →Colorado’s social experiment that is commercial pot continues to roll-out without any obvious setbacks. Among the many unknowns, a few facts begin to emerge. Revenue from retail cannabis is about 50% of the state legislature’s projection, and, as Mark Kleiman and other policy analysts have explained, with more producers entering the market, supply will undercut the price of retail cannabis, as now occurs in CO.
Read more →Faded marijuana stocks shouldn’t come as a big surprise. There’s a discrepancy between the allures of a perceived expanding market, and the price a post-prohibitonary product could fetch. As retail investors are keen to point out, it’s too soon to tell how the federal administration will influence the cannabis industry in a post 2016 election period.
Read more →Representatives from federally recognized tribes in over 20 states convened in Washington on Friday to discuss the implications of legalizing cannabis. Professor of drug policy and crime control, Mark Kleiman, attended the conference as a keynote speaker.
Read more →D.C. legislators upended Congressional efforts to kill the November ’14 voter-approved ballot measure to legalize the possession, growing, and gifting of cannabis. Unable to implement the measure in January following federal appropriations bill restrictions, it now appears that D.C. has laid a legal premise to enact the measure.
Read more →